Company

Easywell Biomedicals, Inc.

Headquarters: Hsinchu City, Taiwan

TWSE: 1799 +7.19%

Market Cap

TW$15.36 Billion

TWD as of July 1, 2024

US$471.6 Million

Market Cap History

Easywell Biomedicals, Inc. market capitalization over time

Evolution of Easywell Biomedicals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Easywell Biomedicals, Inc.

Detailed Description

Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. The company is developing TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. It also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine. It also provides medical devices, including digital clinical thermometers, infrared ear thermometers, and transcutaneous electrical nerve stimulation products for pain relief. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Easywell Biomedicals, Inc. has the following listings and related stock indices.


Stock: TWSE: 1799 wb_incandescent

Details

Headquarters:

No.10, Yanfa 2nd Road

Hsinchu Science Park

Hsinchu City, 30076

Taiwan

Phone: 886 3 666 9596

Fax: 886 3 666 9697